Publications by authors named "Pratiti Bandopadhayay"

56Publications

Advances in the classification and treatment of pediatric brain tumors.

Curr Opin Pediatr 2021 Feb;33(1):26-32

Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

View Article and Find Full Text PDF
February 2021

Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.

Cell 2020 Dec 30;183(6):1617-1633.e22. Epub 2020 Nov 30.

Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada; Department of Pediatrics, McGill University, and The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada. Electronic address:

View Article and Find Full Text PDF
December 2020

Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.

J Neurooncol 2020 Sep 11;149(2):253-262. Epub 2020 Aug 11.

Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorder Center, 450 Brookline Ave, Boston, MA, 02215-5450, USA.

View Article and Find Full Text PDF
September 2020

Mechanisms and therapeutic implications of hypermutation in gliomas.

Nature 2020 04 15;580(7804):517-523. Epub 2020 Apr 15.

Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
April 2020

The "Risk" in Pediatric Low-Grade Glioma.

Cancer Cell 2020 04;37(4):424-425

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
April 2020

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.

Nature 2020 02 5;578(7793):102-111. Epub 2020 Feb 5.

The Broad Institute of MIT and Harvard, Cambridge, MA, USA.

View Article and Find Full Text PDF
February 2020

The Power of Human Cancer Genetics as Revealed by Low-Grade Gliomas.

Annu Rev Genet 2019 12;53:483-503

Departments of Pediatric and Human Genetics, McGill University and the Research Institute of the McGill University Health Center, Montreal, Quebec H4A 3J1, Canada; email:

View Article and Find Full Text PDF
December 2019

Longitudinal molecular trajectories of diffuse glioma in adults.

Nature 2019 12 20;576(7785):112-120. Epub 2019 Nov 20.

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.

View Article and Find Full Text PDF
December 2019

Towards Immunotherapy for Pediatric Brain Tumors.

Trends Immunol 2019 08 19;40(8):748-761. Epub 2019 Jun 19.

Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3052, Australia; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3083, Australia. Electronic address:

View Article and Find Full Text PDF
August 2019

Old meet new-the path to combination treatments in pediatric low-grade gliomas.

Neuro Oncol 2019 02;21(2):143-145

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.

View Article and Find Full Text PDF
February 2019

Management of pediatric low-grade glioma.

Curr Opin Pediatr 2019 02;31(1):21-27

Division of Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta.

View Article and Find Full Text PDF
February 2019

Case-based review: pediatric medulloblastoma.

Neurooncol Pract 2017 Sep 11;4(3):138-150. Epub 2017 Aug 11.

Division of Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, 550 16th Street, 4th Floor, San Francisco, CA 94158 (C.K., S.M.); Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 (R.P.); Brain Tumor Institute, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010 (R.P., E.H.); Division of Hematology/Oncology, Center for Cancer and Blood Disorders, Children's National Health Systems, 111 Michigan Avenue NW, Washington, DC 20010 (R.P., E.H.); Department of Radiation Oncology, University of California, 1825 4th Street, San Francisco, San Francisco, CA 94158 (D.R., S.B.); Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, M779, San Francisco, CA 94143 (C.R., S.M.); Dana-Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Avenue, Boston, MA 02215 (P.B.); Department of Pediatrics, Harvard Medical School, Boston, MA 02215 (P.B.); Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142 (P.B.); Division of Neuropathology, Department of Pathology, University of California, San Francisco, 505 Parnassus Avenue, M551, Box 0102 San Francisco, CA 94143 (D.S.); Department of Radiology, University of California, San Francisco, 550 Parnassus Avenue, M327, San Francisco, CA 94143 (M.A., S.C.); Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, 550 Sandler Neurosciences, 625 Nelson Rising Lane, 402B, Box 0434, San Francisco, CA 94158 (S.M.).

View Article and Find Full Text PDF
September 2017

Open data: Spot data glitches before publication.

Nature 2017 10;550(7676):333

Dana Farber Cancer Institute, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
October 2017

Brainstem angiocentric gliomas with MYB-QKI rearrangements.

Acta Neuropathol 2017 Oct 12;134(4):667-669. Epub 2017 Aug 12.

Department of Pathology, Sainte-Justine Hospital, Université de Montréal, Montréal, QC, Canada.

View Article and Find Full Text PDF
October 2017

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.

J Neurooncol 2017 Oct 21;135(1):201-211. Epub 2017 Jul 21.

Pediatric Neuro-Oncology Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital and Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article and Find Full Text PDF
October 2017

Population Control: Cortical Interneurons Modulate Oligodendrogenesis.

Neuron 2017 May;94(3):415-417

Department of Neurobiology, Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
May 2017

Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.

Neuro Oncol 2017 Jul;19(7):986-996

Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Department of Pathology, Department of Radiology, Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts; Department of Medical Oncology, Oncologic Pathology, Department of Pediatric Oncology, Department of Cancer Biology, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pathology, Department of Neurosurgery, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Pratiti Bandopadhayay, Broad Institute of MIT and Harvard, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
July 2017

Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature.

J Pediatr Hematol Oncol 2016 08;38(6):479-85

*Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK†Pediatric Neuro-Oncology, Dana-Farber Cancer InstituteDepartments of ‡Pediatric Hematology/Oncology§Neurology∥Radiation Oncology¶Neurosurgery#Radiology, Boston Children's Hospital**Department of Pathology, Brigham and Women's Hospital, Boston, MA.

View Article and Find Full Text PDF
August 2016

Tyrosine receptor kinase B is a drug target in astrocytomas.

Neuro Oncol 2017 01 10;19(1):22-30. Epub 2016 Jul 10.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (J.N., S.X., V.L., Y.S., P.B., R.B., T.M.R., C.D.S., R.A.S., J.J.Z.); Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts (J.N., S.X., V.L., T.M.R., J.J.Z.); Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (S.H.R., R.B., K.L.L., W.C.H.); Broad Institute, Boston, Massachusetts (P.B., R.B., W.C.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., K.L.L.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.)

View Article and Find Full Text PDF
January 2017

Myxopapillary ependymomas in children: imaging, treatment and outcomes.

J Neurooncol 2016 Jan;126(1):165-174

Dana-Farber Cancer Institute and Boston Children's Hospital, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, 450 Brookline Ave, Boston, 02215, USA.

View Article and Find Full Text PDF
January 2016

Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.

Neuro Oncol 2015 Nov 29;17(11):1486-96. Epub 2015 Mar 29.

Department of Cancer Biology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts (G.B., P.B., B.R.P., S.E.S., B.T., R.F.-L., C.S., R.S., R.B.); Broad Institute, Cambridge, Massachusetts (G.B., P.B., B.R.P., S.E.S., B.T., R.F.-L., T.G., R.B.); Pediatric Neuro-Oncology Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Dana-Farber Cancer Institute and Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts (P.B., L.C.G., M.W.K.); Liver Cancer Program, Tisch Cancer Institute, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York (Y.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.R., S.S., P.Y.W., A.H.L., K.L.L., J.A.C.); Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.R., L.R., B.R., C.L.M., K.L.L.); Department of Neurosurgery, Acibadem University Medical Center, Istanbul, Turkey (M.O.); Department of Pathology, Acibadem University Medical Center, Istanbul, Turkey (A.S.); Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts (L.C.G.); Departement de Cancerologie de l'enfant et de l'adolescent, Gustave Roussy and Unité Mixte de Recherche 8203 du Centre National de la Recherche Scientifique, Université Paris-Sud, Villejuif, France (J.G.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.).

View Article and Find Full Text PDF
November 2015

Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.

Nat Med 2014 Jul 29;20(7):732-40. Epub 2014 Jun 29.

1] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [2] Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA. [3] Stanford Cancer Institute, Stanford University Medical Center, Stanford, California, USA.

View Article and Find Full Text PDF
July 2014

Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Biochim Biophys Acta 2014 Apr 28;1845(2):294-307. Epub 2014 Feb 28.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
April 2014

Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database.

Pediatr Blood Cancer 2014 Jul 30;61(7):1173-9. Epub 2014 Jan 30.

Division of Pediatric Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF
July 2014

BET bromodomain inhibition of MYC-amplified medulloblastoma.

Clin Cancer Res 2014 Feb 2;20(4):912-25. Epub 2013 Dec 2.

Authors' Affiliations: Departments of Cancer Biology and Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Pediatric Neuro-Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology/Oncology, Boston Children's Hospital; Center for Cancer Genome Characterization, Dana-Farber Cancer Institute, Boston; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Departments of Neurology and Neurological Sciences and Neurosurgery, Stanford University School of Medicine; Stanford Cancer Institute, Stanford University Medical Center, Stanford; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla; Department of Neurology, Pediatrics, and Neurosurgery, University of California, San Francisco, California; and Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

View Article and Find Full Text PDF
February 2014

The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases.

Pathology 2011 Jan;43(1):9-16

Department of Anatomical Pathology, Royal Children's Hospital, Melbourne, Australia.

View Article and Find Full Text PDF
January 2011

Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.

Pathology 2008 Dec;40(7):664-70

Department of Anatomical Pathology, Royal Children's Hospital, Flemington Road, Parkville, Vic 3052, Australia.

View Article and Find Full Text PDF
December 2008

Arousal responses and risk factors for sudden infant death syndrome.

Sleep Med 2002 Dec;3 Suppl 2:S61-5

Department of Paediatrics and Ritchie Centre for Baby Health Research, Monash University, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
December 2002

Effects of age and sleeping position on arousal from sleep in preterm infants.

Sleep 2002 Nov;25(7):746-50

Department of Paediatrics and Ritchie Centre for Baby Health Research, Monash University, Clayton, Victoria, Australia.

View Article and Find Full Text PDF
November 2002

Temperament ratings do not predict arousability in normal infants and infants at increased risk of sudden infant death syndrome.

J Dev Behav Pediatr 2002 Oct;23(5):365-70

Department of Paediatrics and Ritchie Centre for Baby Health Research, Monash University, Wellington Road, Clayton, Victoria, Australia.

View Article and Find Full Text PDF
October 2002